Here you'll find everything from the Patient Journey 2017 supplement to our June issue.
Here you'll find everything from our June 2017 issue, including our Pharma Report, our Hall of Femme, and two roundtable discussions on media and oncology.
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.
Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.
Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.
Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.
Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.
Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.
Here you'll find Sara Holoubek's deep dive into how pharma is tackling some of its biggest challenges.